Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FertiTOX - Platform for Fertility Related Gonadotoxicity of Cancer Therapies

NCT05885048 is registered in ClinicalTrials.gov with Michael von Wolff as lead sponsor.

NCT NCT05885048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05885048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FertiTOX - Platform for Fertility Related Gonadotoxicity of Cancer Therapies
Lead sponsor
Michael von Wolff
Phase
Observational
Overall status
Recruiting
Start date
December 1, 2023
Completion date
December 31, 2038
Enrollment
7,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, effects of immunotherapy, fertility issues, fertility preservation, toxicity due to chemotherapy, toxicity due to radiotherapy